None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 60 years; 2. ASA classification I-II; 3. Elective three-port laparoscopic cholecystectomy is planned.
Exclusion criteria
Exclusion criteria: 1. Those with contraindications to abdominal wall nerve block: abnormal coagulation function, infection at the puncture site, allergy to local anesthetics, etc.; 2. Those with a history of chronic pain or neuropathic pain who have been taking painkillers for a long time; 3. Unable to cooperate with the researcher for any reason: hearing or visual impairment, language comprehension impairment, mental illness, etc.; 4. BMI >=35kg/m^2; 5. Patients with advanced liver and renal insufficiency; 6. Those who have had abdominal surgery in the past; 7. Those who have a history of postoperative nausea and vomiting or suffer from motion sickness; 8. Has participated in other researches.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of sufentanil 24 hours after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean arterial pressure and heart rate of the patients at the time of entering the room, at the time of skin resection, immediately after the establishment of pneumoperitoneum, at the beginning of the cholecystectomy for 5min, at the time of surgical suture and 5min after extubation;Nerve block operation time, extubation time;NRS score at rest and cough;Intraoperative dosage of fentanyl, propofol, and remifentanil;Postoperative analgesic dose of flurbiprofen and dezocine at 12h and 24h;24h postoperative quality of life recovery questionnaire (QoR-40) score;The severity of postoperative nausea and vomiting;Postoperative infection, hematoma, subcutaneous emphysema and shoulder pain;24h postoperative analgesia satisfaction;The number of patients receiving tropisetron in each group after surgery; | — |
Countries
China
Contacts
Affiliated Hospital of Xuzhou Medical University